These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38973128)

  • 41. The role of uric acid in the development of cardiovascular disease.
    Borghi C
    Curr Med Res Opin; 2015; 31 Suppl 2():1-2. PubMed ID: 26414729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uric acid metabolism in pre-hypertension and the metabolic syndrome.
    Rizzo M; Obradovic M; Labudovic-Borovic M; Nikolic D; Montalto G; Rizvi AA; Mikhailidis DP; Isenovic ER
    Curr Vasc Pharmacol; 2014; 12(4):572-85. PubMed ID: 23627979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of serum uric acid on blood-pressure lowering treatment.
    Grassi G
    Curr Med Res Opin; 2017 Nov; 33(sup3):15-19. PubMed ID: 28952389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.
    Borghi C; Palazzuoli A; Landolfo M; Cosentino E
    Heart Fail Rev; 2020 Jan; 25(1):43-51. PubMed ID: 31745840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout.
    Krishnan E
    Rheumatology (Oxford); 2010 Jul; 49(7):1229-38. PubMed ID: 20202928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The problem of cardio-renal diseases in patients with gout.
    Ferri C
    Curr Med Res Opin; 2017 Nov; 33(sup3):9-13. PubMed ID: 28952391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk.
    Borghi C; Agnoletti D; Cicero AFG; Lurbe E; Virdis A
    Hypertension; 2022 Sep; 79(9):1927-1936. PubMed ID: 35658505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia.
    Crawley WT; Jungels CG; Stenmark KR; Fini MA
    Redox Biol; 2022 May; 51():102271. PubMed ID: 35228125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes.
    Li LX; Dong XH; Li MF; Zhang R; Li TT; Shen J; Shen J; Bao YQ; Jia WP
    J Hypertens; 2015 Mar; 33(3):482-90; discussion 490. PubMed ID: 25405332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The paradoxical relationship between serum uric acid and cardiovascular disease.
    Lippi G; Montagnana M; Franchini M; Favaloro EJ; Targher G
    Clin Chim Acta; 2008 Jun; 392(1-2):1-7. PubMed ID: 18348869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hyperuricemia and the metabolic syndrome].
    Mitu F; Drăgan MV
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1001-5. PubMed ID: 20191866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperuricemia, the heart, and the kidneys - to treat or not to treat?
    Petreski T; Ekart R; Hojs R; Bevc S
    Ren Fail; 2020 Nov; 42(1):978-986. PubMed ID: 32972284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uric acid as a cardiometabolic risk factor: to be or not to be.
    Kanbay M; Afsar B; Covic A
    Contrib Nephrol; 2011; 171():62-67. PubMed ID: 21625091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gout and Metabolic Syndrome: a Tangled Web.
    Thottam GE; Krasnokutsky S; Pillinger MH
    Curr Rheumatol Rep; 2017 Aug; 19(10):60. PubMed ID: 28844079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study.
    Redon P; Maloberti A; Facchetti R; Redon J; Lurbe E; Bombelli M; Mancia G; Grassi G
    J Hypertens; 2019 Feb; 37(2):380-388. PubMed ID: 30074564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanistic Insights of Soluble Uric Acid-related Kidney Disease.
    Pan J; Shi M; Ma L; Fu P
    Curr Med Chem; 2020; 27(30):5056-5066. PubMed ID: 30526453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study.
    Viazzi F; Garneri D; Leoncini G; Gonnella A; Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Agabiti Rosei E; Deferrari G; Pontremoli R
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):921-7. PubMed ID: 24675005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
    Tsouli SG; Liberopoulos EN; Mikhailidis DP; Athyros VG; Elisaf MS
    Metabolism; 2006 Oct; 55(10):1293-301. PubMed ID: 16979398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.